Drug Shortage Report for NIMOTOP
Report ID | 49559 |
Drug Identification Number | 02325926 |
Brand name | NIMOTOP |
Common or Proper name | Nimodipine tablets |
Company Name | BAYER INC |
Market Status | MARKETED |
Active Ingredient(s) | NIMODIPINE |
Strength(s) | 30MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100's |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-10-13 |
Actual start date | |
Estimated end date | 2018-10-16 |
Actual end date | 2018-10-15 |
Shortage status | Resolved |
Updated date | 2018-10-16 |
Company comments | Product is now available to market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-07-19 | French | Compare |
v3 | 2018-07-19 | English | Compare |
v2 | 2018-05-16 | French | Compare |
v1 | 2018-05-16 | English | Compare |